Causal AI for
Human Health
At insitro, we combine 20+ petabytes of automated cellular experiments with population-scale genetics to build Physical AI systems that reveal the true causal drivers of human disease and deliver targeted therapeutics.
Scroll for More
TherMLTM
TherML is insitro’s modality-agnostic, AI-driven therapeutics design engine, spanning small molecules, oligonucleotides, and complex biologics. By matching the best-fit modality to each target and indication, TherML shifts drug discovery from stochastic screening to predictive, adaptive engineering—advancing better molecules, faster.
“Human data tells us which biological changes matter for disease; cellular data tells us what causes those changes. AI, operating across both, identifies mechanisms that are consistent at both scales.”
Daphne Koller
Founder & CEO
A Team Greater Than the Sum of Its Parts
We’ve built a unique culture where life scientists, data scientists, engineers, and drug hunters work together to identify the most important questions, design and scale experiments, build models, and analyze the results. Our differences enhance our strengths, and our collective expertise comes together to generate scientific breakthroughs.
Follow Our Progress
Browse insitro’s latest news, videos, publications, and speaking engagements to stay informed about our progress in redefining drug discovery and development.
